Chhatwal Karanjot, Deighton Alexander, Dhir Abhay, Kumar Varun Vijay, Titus-Glover Sean, Shah Darsh, Holt Luke
Medical student, Imperial College London, London, UK.
Foundation year 1 doctor, Homerton Healthcare NHS Foundation Trust, London, UK.
Future Healthc J. 2024 Apr 19;11(1):100128. doi: 10.7861/fhj.2023-0033. eCollection 2024 Mar.
With health and surgery increasingly aided by digital technologies, there exists a growing impetus to understand how such tools must integrate into existing clinical pathways to ensure a positive impact on patient and organisational outcomes. Consequently, this study sought to collate evidence on the use of digital technology in cardiac reperfusion surgeries. We systematically searched three scientific databases for relevant articles. In total, 1,092 articles were retrieved, with 126 screened using inclusion/exclusion criteria, and 21 selected for analysis. Articles reported on the use of virtual reality, mHealth and telehealth in cardiovascular reperfusion procedures, ranging from surgical training regimens to postoperative rehabilitation. Here, despite clinical advantages, limitations were highlighted, including cost, ineffective interfaces and extensive training needed to operate novel digital tools. Nevertheless with further development and input from patient stakeholders, many limitations look set to dematerialise and provide tangible improvements to the benefit of patients and hard-pressed health institutions.
随着健康和手术越来越多地得到数字技术的辅助，人们越来越迫切地想要了解这些工具必须如何融入现有的临床路径，以确保对患者和组织成果产生积极影响。因此，本研究旨在收集有关数字技术在心脏再灌注手术中应用的证据。我们系统地在三个科学数据库中搜索相关文章。总共检索到1092篇文章，其中126篇根据纳入/排除标准进行筛选，21篇被选作分析。文章报道了虚拟现实、移动健康和远程医疗在心血管再灌注程序中的应用，范围从手术训练方案到术后康复。在此，尽管有临床优势，但也突出了一些局限性，包括成本、无效的界面以及操作新型数字工具所需的广泛培训。然而，随着进一步的发展以及患者利益相关者的参与，许多局限性似乎将消失，并为患者和压力重重的医疗机构带来切实的改善。
